News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Belite Bio, Inc
Belite Bio Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
August 09, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
August 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on August 12, 2024, to Discuss Second Quarter 2024 Financial Results
August 05, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Present at the JonesHealthcare Seaside Summit
July 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Receives Sakigake (Pioneer Drug) Designation of Tinlarebant for Stargardt Disease in Japan
June 12, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor Conference
May 14, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate Update
May 13, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor Conference
May 13, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
May 08, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On Tinlarebant
May 06, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual Meeting
May 06, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual Meeting
May 01, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Announces $25 Million Registered Direct Offering
April 25, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
March 22, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
March 11, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 11, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
March 06, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
March 04, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 07, 2024
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
November 30, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Participate in the BTIG Ophthalmology Day
November 20, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
November 13, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
November 07, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual Meeting
November 06, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
October 27, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
August 08, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
August 04, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
July 27, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Completes Enrollment in Pivotal Global Phase 3 DRAGON Trial Evaluating Oral Tinlarebant for Stargardt Disease
July 24, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Belite Bio Announces Pricing of $30 Million Underwritten Public Offering of American Depositary Shares and Warrants
May 30, 2023
From
Belite Bio, Inc
Via
GlobeNewswire
Tickers
BLTE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.